JPS6158442B2 - - Google Patents
Info
- Publication number
- JPS6158442B2 JPS6158442B2 JP58039768A JP3976883A JPS6158442B2 JP S6158442 B2 JPS6158442 B2 JP S6158442B2 JP 58039768 A JP58039768 A JP 58039768A JP 3976883 A JP3976883 A JP 3976883A JP S6158442 B2 JPS6158442 B2 JP S6158442B2
- Authority
- JP
- Japan
- Prior art keywords
- levulinic acid
- amount
- weight
- skin
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 81
- 210000002374 sebum Anatomy 0.000 claims description 50
- 229940040102 levulinic acid Drugs 0.000 claims description 44
- 239000002537 cosmetic Substances 0.000 claims description 37
- 230000000694 effects Effects 0.000 claims description 31
- 230000028327 secretion Effects 0.000 claims description 31
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 26
- -1 alkali metal salt Chemical class 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 23
- 239000004615 ingredient Substances 0.000 claims description 16
- 239000002585 base Substances 0.000 claims description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 13
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 13
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 235000003130 Arctium lappa Nutrition 0.000 claims description 7
- 235000008078 Arctium minus Nutrition 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 6
- 229960000458 allantoin Drugs 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 235000003351 Brassica cretica Nutrition 0.000 claims description 5
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 5
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 5
- 235000010460 mustard Nutrition 0.000 claims description 5
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 claims description 5
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 240000005528 Arctium lappa Species 0.000 claims 1
- 244000056139 Brassica cretica Species 0.000 claims 1
- IZMHKHHRLNWLMK-UHFFFAOYSA-M chloridoaluminium Chemical compound Cl[Al] IZMHKHHRLNWLMK-UHFFFAOYSA-M 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 28
- 239000006210 lotion Substances 0.000 description 21
- 238000005562 fading Methods 0.000 description 15
- 230000001629 suppression Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000208843 Arctium Species 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000002845 discoloration Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 241000219198 Brassica Species 0.000 description 4
- 241000219287 Saponaria Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000017 mucous membrane irritation Toxicity 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940058352 levulinate Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940078480 calcium levulinate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 231100001032 irritation of the eye Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940058349 sodium levulinate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Description
本発明は新規な皮脂分泌抑制効果(作用)を有
する皮膚化粧用組成物に関し、更に詳しくは皮膚
に対して安全で顔面等における皮脂分泌を抑制し
て化粧くずれを防止し、化粧もちを良くする新規
な皮膚化粧用組成物に関するものである。
皮表に分泌される脂質(以下、皮脂という)
は、角質層の柔軟さと湿度を適度に保ち、外界か
らの有害な物質の吸収を妨げ、また制御し、更に
細菌や真菌類の感染などを防ぐ役目を有するなど
生体皮膚がその恒常性を保つ上で欠かすことので
きない重要な機能を担つている。しかしながら、
一方で皮脂は化粧くずれの原因ともなつている。
すなわち、後述するようにメイクアツプ化粧を施
した皮膚は、皮脂の分泌量が多くなるとまず最初
に所謂“照り”が起こり、続いて“化粧浮き”、
“色ぐすみ”、“褪色”あるいは“顔料のよれ”が
認められるようになりメイクアツプ化粧はくずれ
てしまう。
化粧くずれの起こり方は、使用者の皮脂分泌量
によつて大きく異なり、特に温度や湿度あるいは
運動量の影響が大きいが、一般には夏季の日中に
おいてメイクアツプ化粧後2〜3時間経過すると
化粧くずれが認められるようになる。
そこでメイクアツプ化粧料を使用するほとんど
すべての女性から化粧くずれのしにくい、化粧も
ちのよい化粧料の実現が久しく望まれていた。そ
のために耐水性の優れた仕上化粧料基剤の開発や
顔料の表面処理などが種々研究されているが、未
だ充分満足するべきものは得られていない。
本発明者等は、化粧くずれに及ぼす皮脂の影響
並びに化粧くずれの防止に関し鋭意広範囲な系統
的研究を行なつた結果、
(1) 一般に顔面における皮脂分泌量の多い部位は
“Tゾーン”と呼ばれる、ひたい、鼻、小鼻、
あご等の顔面正中線周辺部の皮膚であること。
(2) 化粧くずれもこの“Tゾーン”において顕著
に生起、発現すること。
(3) 化粧くずれを防ぎ、化粧もちを良くするため
の最も効果的な方法は断面の皮脂分泌を抑制す
ることであること。
(4) 皮膚に施用しても安全で、迅速に皮脂分泌抑
制効果を発現し得るものとしてレブリン酸また
はその塩類があり、しかもそれらの化合物は
0.0001〜0.04%の低濃度域において顕著な作用
効果を発揮することを見出し、本発明を完成し
た。
すなわち、本発明はレブリン酸および/または
その塩(以下、便宜上、レブリン酸系化合物とい
う)を水性の化粧料基剤に処方成分の総量を基準
として0.0001〜0.04重量%配合してなる皮脂分泌
抑制効果の優れた皮膚化粧用組成物である。
本発明における前記のレブリン酸の塩として、
例えばアンモニウム塩、トリエタノールアミン塩
等のアルカノールアミン塩、ナトリウム塩、カリ
ウム塩等のアルカリ金属塩、カルシウム塩、マグ
ネシウム塩等のアルカリ土類金属塩等が好ましい
ものとして挙げることができる。
レブリン酸及び/またはその塩の配合量は、処
方成分の総量(該化粧用組成物の重量)を基準と
して、0.0001〜0.04重量%、好ましくは0.001〜
0.01重量%である。0.0001%重量%未満では、皮
脂分泌抑制効果が低くて化粧くずれ防止効果が得
られ難く、0.04重量%を超えると、目に入つた場
合、眼粘膜刺激を生じせしめる可能性があるので
好ましくない。
なお、西独特許公開第2436468号公報には、レ
ブリン酸を多量(1〜20重量%)含有することを
特徴とするモイスチヤー効果を目的とした皮膚化
粧料が開示されているが、このような高濃度では
皮膚刺激を生ぜしめる可能性があり、本発明の化
粧用組成物には適用されない。そしてこの中に
は、皮脂分泌抑制効果や化粧くずれ防止効果につ
いて全く示唆されていない。
本発明において、前記レブリン酸系化合物を配
合する水性の化粧料基剤としては、皮膚化粧料に
おけるローシヨン状基剤や透明ゲル状の化粧料基
剤が特に好ましいものとして例示されるが、最も
単純な水単独でもよい。本発明の皮膚化粧用組成
物における水の含有量は、通常50〜99重量%であ
る。ローシヨン基剤におけるアルコールの配合量
は、処方成分の総量を基準として高々40重量%、
好ましくは10〜30重量%である。配合される他の
成分としては、香料、着色剤、防腐剤等の他、必
要に応じて収れん剤、可溶化剤、保湿剤、PH調整
剤、植物抽出エキス等を配合しても良い。
本発明で得られるローシヨン状の皮膚化粧用組
成物は、長期保存しても沈澱物の生成や変色、変
臭に惹起することなく極めて安全で、使用に際し
ては皮膚刺激なく、肌に清涼感を与え、皮脂分泌
抑制効果に優れ、化粧くずれを防止して化粧もち
を良好ならしめるものであつて、前記レブリン酸
系化合物の作用効果の特異性は著しい。
透明ゲル状化粧料の基剤において、アルコール
を配合する場合の量は、処方成分の総量に対して
高々40重量%、好ましくは10〜30重量%である。
透明ゲル状化粧料の基剤には、例えばカルボキ
シビニルポリマーやヒドロキシプロピルセルロー
ズ等の、公知の高分子物質からなる増粘剤が使用
される。その配合量は通常0.1〜1重量%、好ま
しくは0.2〜0.5重量%である。配合される他の成
分としては、香料、着色剤、防腐剤等の他、必要
に応じて収れん剤、可溶化剤、保湿剤、PH調整
剤、植物抽出エキス等を配合してもよい。
本発明で得られる透明ゲル状の皮膚化粧用組成
物は、長期保存しても変色、変臭、不透明化等を
惹起することなく、極めて安定で、使用に際して
は皮膚刺激なく、肌に清涼感を与え、皮脂分泌抑
制効果に優れ、化粧くずれを防止して、化粧もち
を良好ならしめるものであつて、前記レブリン酸
系化合物の作用効果の特異性は著しい。
本発明の皮膚化粧用組成物において、前記レブ
リン酸系化合物と、更にパラフエノールスルホン
酸亜鉛、アラントインクロルヒドロキシルアルミ
ニウム、アラントインジヒドロキシルアルミニウ
ム、塩基性塩化アルミニウムからなる群より選択
された少なくとも一つの有機多価金属塩、または
ゴボウ、オランダカラシ、常春ツタ、サボンソウ
からなる群より選択された薬用植物の少なくとも
一つの1・3−ブチレングリコール抽出物を、あ
るいは前記レブリン酸系化合物と前記有機多価金
属塩と前記薬用植物の1・3−ブチレングリコー
ル抽出物との三者を併用する場合は、前記レブリ
ン酸系化合物を単独使用した場合に比較して、よ
り優れた皮脂抑制効果および化粧くずれ防止効果
を発現し、化粧もち効果を更に同上せしめること
ができる。
前記の有機多価金属塩は、前記の一つまたは二
つ以上組合せて配合することができ、その配合量
は、処方成分の総量を基準として高々3.0重量
%、好ましくは0.5〜2.0重量%である。前記薬用
植物の1・3−ブチレングリコール抽出物は、ゴ
ボウ、オランダカラシ、常春ツタ、サボンソウか
らなる群より選択された薬用植物の少なくとも一
つを、1・3ブチレングリコールまたはその水性
溶液によつて抽出したものである。
この抽出物の中で最も好ましいものは、前記薬
用植物の少なくとも一つを1・3−ブチレングリ
コール水性溶液で抽出したものである。
その一例を挙げると、ゴボウ、オランダカラ
シ、常春ツタ、サボンソウの夫々10Kgに例えば40
%1・3−ブチレングリコール水溶液20を加
え、20〜25℃にて10〜15日間浸漬した後、遠心分
離する。その各残渣に20%1.3−ブチレングリコ
ール水溶液20を加え同様の方法にて浸漬、分離
する。
前記薬用植物抽出物は抽出液のかたちで基剤に
配合してもよく、また1・3−ブチレングリコー
ルを適度に留去してエキスのかたちで配合しても
よい。化粧用組成物への配合量は処方成分の総量
を基準として、乾燥固形分当り高々2.0重量%、
好ましくは0.1〜1.0重量%である。
本発明の前記皮膚化粧用組成物は、洗顔や拭き
取りによつて皮脂や汚れを除き肌を整えた後、顔
面、特に皮脂分泌量の多いTゾーン(ひたい、
鼻、小鼻、あご等)に適量施用すると、前記のレ
ブリン酸系化合物または有機多価金属塩、薬用植
物抽出物等とが皮膚にマイルドに作用し、皮脂分
泌を適度に抑制して、さつぱりとした素肌の感触
を永く保持し、しかも“照り”や“脂浮き”の生
成やメイクアツプ化粧料の化粧くずれを防止し
て、化粧もちを顕著に良好ならしめ得る等、その
作用効果の特異性は著しい。
以下、本発明の実施例について説明する。
実施例に示した部とは重量部を、%とは重量%
を意味する。
実施例 1
(本発明の化粧水)
エタノール15部、ポリオキシエチレンラウリル
エーテル(20E.O.)(可溶化剤)0.3部、メチルパ
ラペン0.1部、香料0.1部、グリセリン1.0部、ビタ
ミンAパルミテート0.01部、水83.48部と下記の
レブリン酸またはその塩類0.01部からなる本発明
の皮膚化粧用組成物(皮脂分泌抑制作用を有する
皮膚化粧水)を常法にて調製した。また比較のた
めにレブリン酸系化合物のみを添加しない対照の
化粧水を調製した。尚使用した各レブリン酸系化
合物と後記第3表乃至第10表に示したその各記号
は下記の通りである。
A:レブリン酸
B:レブリン酸のトリエタノールアミン塩
C:レブリン酸アンモニウム
D:レブリン酸ナトリウム
E:レブリン酸カルシウム
得られた各化粧水の皮脂分泌抑制効果は以下の
実験によつて評価した。
Γ皮脂分泌抑制率の測定法
8名〜16名の被験者の前額部の皮脂を75%エタ
ノールを含浸した脱脂綿で充分に拭き取り、全体
を四部位に区分する。三部位にはそれぞれ異なつ
た試料を塗布し、他の一部位には試料を塗布せず
対照試験に用いる。
塗布してから1時間、2時間および3時間後
に、1cm×1cmの大きさの紙(東洋紙
No.6)を30秒間強く圧着することによつて、こ
の時間内に皮表に分泌された皮脂(回復皮脂)を
紙に吸着させ、高石の方法(日本皮膚科学会雑
誌、第70巻、P.433、1960)によつてオスミウム
酸の蒸気中に2分間曝して黒化した紙を更に24
時間空気中に曝した後、分光反射率計を用いて黒
化した紙の吸光度を測定し、皮脂を吸着させな
い紙の吸光度を差し引く。対照試験部位の4時
間後の回復皮脂量を飽和皮脂量として、飽和皮脂
量に対する各試料塗布部位の回復皮脂量の比率を
それぞれの吸光度から求め、皮脂分泌抑制率を以
下の式によつて算出する。
皮脂分泌抑制率(%)=100−回復皮脂を吸着させた紙より算出した吸光度/飽和皮脂を吸着させた紙
より算出した吸光度×100
化粧くずれ防止効果は以下の実験によつて評価
した。
Γ化粧くずれ防止効果測定法
20名の健常女性パネラーを対象に、温度27.5〜
28.5℃、湿度55〜60%に設定した環境試験室内で
以下の試験を行つた。
(1) 1時間環境順応
(2) クレジングクリームを使用して顔全面の皮脂
を拭き取る。
(3) フレツシユナーとコツトンで同様に拭き取
る。
(4) 左右顔面のいずれか一方の側の前額部、鼻、
小鼻を中心とした皮脂分泌の多い部分に本発明
の化粧用組成物等の試料組成物を塗布する。な
お、他の一方の側の顔面には、レブリン酸系化
合物を添加していない化粧料を塗布しコントロ
ールとする。
(5) 顔全面に下記処方のフアンデーシヨンを一定
量塗布する。
(6) 1、2、3、各時間後の化粧くずれの状態を
判定者が評価する。
なお、使用したフアンデーシヨンの処方は下
記の通りである。
マイクロワツクス 10 部
ワセリン 16 〃
イソプロピルミリステート 15 〃
ポリオキシエチレンセチルエーテル(20E.O.
) 6 〃
酸化防止剤 0.06〃
プロピルパラベン 0.1 〃
香 料 0.5 〃
酸化チタン 22.34〃
タルク 23.8 〃
酸化鉄 1.5 〃
イエローオーカー 4.1 〃
カーボンブラツク 0.6 〃
本発明の化粧水および比較用化粧水の化粧くず
れ、色ぐすみ、防止効果を第1表および第2表に
示す。
The present invention relates to a skin cosmetic composition that has a novel sebum secretion suppressing effect (action), and more specifically, it is safe for the skin, suppresses sebum secretion on the face, etc., prevents makeup from fading, and improves makeup retention. The present invention relates to a novel skin cosmetic composition. Lipids secreted on the skin surface (hereinafter referred to as sebum)
It maintains the homeostasis of living skin by maintaining appropriate flexibility and humidity of the stratum corneum, preventing and controlling the absorption of harmful substances from the outside world, and preventing bacterial and fungal infections. It plays an important function that is indispensable. however,
On the other hand, sebum is also the cause of makeup fading.
In other words, as will be described later, when the skin has been applied with make-up makeup, when the amount of sebum secreted increases, the so-called "shininess" will first occur, followed by "makeup floating", and so on.
“Color dullness,” “fading,” or “pigment twisting” becomes noticeable, and your makeup looks ruined. How makeup comes off varies greatly depending on the amount of sebum secreted by the user, and is particularly influenced by temperature, humidity, and amount of exercise, but in general, make-up starts to come off 2 to 3 hours after applying makeup during the daytime in summer. Become recognized. Therefore, almost all women who use make-up cosmetics have long desired the creation of cosmetics that do not easily come off and have long-lasting makeup. For this purpose, various researches have been conducted on the development of finishing cosmetic bases with excellent water resistance and the surface treatment of pigments, but nothing that is fully satisfactory has yet been obtained. The present inventors conducted extensive systematic research on the influence of sebum on makeup discoloration and the prevention of makeup discoloration, and found that (1) Generally, the area on the face with a large amount of sebum secretion is called the "T zone". , forehead, nose, nostrils,
The skin should be around the midline of the face, such as the chin. (2) Makeup fading also occurs and manifests significantly in this "T-zone." (3) The most effective way to prevent makeup from fading and make makeup last longer is to suppress sebum secretion on the cross-section. (4) Levulinic acid or its salts are safe when applied to the skin and can quickly exert the effect of suppressing sebum secretion, and these compounds
The present invention was completed based on the discovery that significant effects are exhibited in the low concentration range of 0.0001 to 0.04%. That is, the present invention provides a sebum secretion suppressing agent which is made by blending levulinic acid and/or its salts (hereinafter referred to as levulinic acid-based compounds for convenience) in an aqueous cosmetic base in an amount of 0.0001 to 0.04% by weight based on the total amount of prescription ingredients. It is a skin cosmetic composition with excellent effects. As the salt of levulinic acid in the present invention,
Preferred examples include alkanolamine salts such as ammonium salts and triethanolamine salts, alkali metal salts such as sodium salts and potassium salts, and alkaline earth metal salts such as calcium salts and magnesium salts. The amount of levulinic acid and/or its salt is 0.0001 to 0.04% by weight, preferably 0.001 to 0.04% by weight, based on the total amount of prescription ingredients (weight of the cosmetic composition).
It is 0.01% by weight. If it is less than 0.0001% by weight, the sebum secretion suppressing effect is low and it is difficult to obtain the effect of preventing makeup from fading, and if it exceeds 0.04% by weight, it may cause eye mucous membrane irritation if it comes into contact with the eyes, which is not preferable. In addition, West German Patent Publication No. 2436468 discloses a skin cosmetic for the purpose of moisturizing effect, which is characterized by containing a large amount (1 to 20% by weight) of levulinic acid. Concentrations may cause skin irritation and are not applicable to the cosmetic compositions of the present invention. Furthermore, there is no suggestion whatsoever about the effect of suppressing sebum secretion or the effect of preventing makeup from fading. In the present invention, as the aqueous cosmetic base in which the levulinic acid-based compound is blended, lotion-like bases and transparent gel-like cosmetic bases for skin cosmetics are particularly preferred, but the simplest ones are Water alone may also be used. The water content in the skin cosmetic composition of the present invention is usually 50 to 99% by weight. The amount of alcohol in the lotion base is at most 40% by weight based on the total amount of prescription ingredients.
Preferably it is 10 to 30% by weight. Other ingredients to be blended include fragrances, colorants, preservatives, and the like, as well as astringents, solubilizers, humectants, PH regulators, plant extracts, and the like, if necessary. The lotion-like skin cosmetic composition obtained according to the present invention is extremely safe without producing precipitates, discoloration, or odor even when stored for a long period of time, and does not irritate the skin when used and leaves a refreshing feeling on the skin. The effects of the levulinic acid compound are remarkable in that it has an excellent effect of inhibiting sebum secretion, prevents makeup from fading, and makes makeup last longer. In the base of a transparent gel cosmetic, the amount of alcohol added is at most 40% by weight, preferably 10 to 30% by weight, based on the total amount of prescription ingredients. A thickener made of a known polymeric substance such as carboxyvinyl polymer or hydroxypropyl cellulose is used as a base for transparent gel-like cosmetics. The amount incorporated is usually 0.1 to 1% by weight, preferably 0.2 to 0.5% by weight. Other ingredients to be blended include perfumes, colorants, preservatives, and the like, as well as astringents, solubilizers, humectants, PH regulators, plant extracts, and the like, if necessary. The transparent gel-like skin cosmetic composition obtained by the present invention is extremely stable without causing discoloration, odor, or opacity even after long-term storage, and does not cause skin irritation when used, giving a refreshing feeling to the skin. The levulinic acid compound has an excellent effect of suppressing sebum secretion, prevents makeup from fading, and makes makeup last longer.The action and effect of the levulinic acid compound is remarkable. In the skin cosmetic composition of the present invention, the levulinic acid compound and at least one organic polymer selected from the group consisting of zinc paraphenolsulfonate, allantoin chlorohydroxyl aluminum, allantoin dihydroxyl aluminum, and basic aluminum chloride are provided. a valent metal salt, or a 1,3-butylene glycol extract of at least one medicinal plant selected from the group consisting of burdock, mustard, evergreen ivy, and soapwort, or the levulinic acid-based compound and the organic polyvalent metal salt. When used in combination with the 1,3-butylene glycol extract of the medicinal plant, a better sebum suppressing effect and makeup smearing prevention effect can be obtained compared to when the levulinic acid compound is used alone. It is possible to further improve the makeup lingering effect. The above-mentioned organic polyvalent metal salts can be blended in one or in combination of two or more, and the blending amount thereof is at most 3.0% by weight, preferably 0.5-2.0% by weight, based on the total amount of prescription ingredients. be. The 1,3-butylene glycol extract of medicinal plants is prepared by extracting at least one medicinal plant selected from the group consisting of burdock, mustard, evergreen ivy, and soapwort using 1,3-butylene glycol or an aqueous solution thereof. This is an extracted version. The most preferred of these extracts is one obtained by extracting at least one of the above-mentioned medicinal plants with an aqueous solution of 1,3-butylene glycol. For example, for each 10 kg of burdock, mustard, everlasting ivy, and soapwort, for example, 40 kg
After adding 20% 1,3-butylene glycol aqueous solution and soaking at 20 to 25°C for 10 to 15 days, centrifugation is performed. Add 20% 1.3-butylene glycol aqueous solution to each residue and immerse and separate in the same manner. The medicinal plant extract may be blended into the base in the form of an extract, or may be blended in the form of an extract after 1,3-butylene glycol is appropriately distilled off. The amount to be incorporated into cosmetic compositions is at most 2.0% by weight per dry solid content, based on the total amount of prescription ingredients.
Preferably it is 0.1 to 1.0% by weight. The skin cosmetic composition of the present invention can be used on the face, especially in the T zone (foreign area) where sebum secretion is high, after removing sebum and dirt by washing or wiping the skin.
When applied in an appropriate amount to the nose, nostrils, chin, etc., the above-mentioned levulinic acid compounds, organic polyvalent metal salts, medicinal plant extracts, etc. have a mild effect on the skin, moderately suppress sebum secretion, and reduce skin irritation. Its unique effects include maintaining the crisp feel of bare skin for a long time, preventing the formation of shine and oil floatation, and preventing the makeup from fading due to make-up cosmetics, making makeup last noticeably better. The sex is remarkable. Examples of the present invention will be described below. In the examples, parts refer to parts by weight, and % refers to % by weight.
means. Example 1 (Lotion of the present invention) 15 parts of ethanol, 0.3 parts of polyoxyethylene lauryl ether (20E.O.) (solubilizer), 0.1 part of methylparaben, 0.1 part of fragrance, 1.0 part of glycerin, 0.01 part of vitamin A palmitate. A skin cosmetic composition of the present invention (a skin lotion having a sebum secretion suppressing effect) consisting of 83.48 parts of water and 0.01 part of the following levulinic acid or its salt was prepared in a conventional manner. For comparison, a control lotion was prepared in which only the levulinic acid compound was not added. The levulinic acid compounds used and their respective symbols shown in Tables 3 to 10 below are as follows. A: Levulinate B: Triethanolamine salt of levulinic acid C: Ammonium levulinate D: Sodium levulinate E: Calcium levulinate The sebum secretion inhibiting effect of each of the obtained lotions was evaluated by the following experiment. Method for measuring Γ sebum secretion inhibition rate The sebum on the foreheads of 8 to 16 subjects was thoroughly wiped off with absorbent cotton impregnated with 75% ethanol, and the whole body was divided into four parts. A different sample is applied to each of the three areas, and the other area is used as a control test without applying any sample. 1 hour, 2 hours and 3 hours after application
No. 6) for 30 seconds, the sebum secreted on the skin surface (recovery sebum) is adsorbed to the paper, and the method of Takaishi (Journal of the Japanese Dermatological Association, Vol. 70, P.433, 1960), the paper was blackened by exposing it to osmic acid vapor for 2 minutes.
After being exposed to air for an hour, the absorbance of the blackened paper is measured using a spectroscopic reflectometer, and the absorbance of the paper that does not absorb sebum is subtracted. The amount of recovered sebum in the control test area after 4 hours is taken as the saturated sebum amount, and the ratio of the amount of recovered sebum in each sample application area to the saturated sebum amount is determined from each absorbance, and the sebum secretion suppression rate is calculated using the following formula. do. Sebum secretion suppression rate (%) = 100 - Absorbance calculated from paper adsorbed with recovered sebum/Absorbance calculated from paper adsorbed saturated sebum x 100 The effect of preventing makeup from fading was evaluated by the following experiment. ΓMeasurement method for prevention of makeup deterioration A panel of 20 healthy women was tested at a temperature of 27.5~
The following tests were conducted in an environmental test room set at 28.5°C and humidity between 55% and 60%. (1) Acclimatize for 1 hour (2) Wipe away sebum from the entire face using cleansing cream. (3) Wipe off in the same way with Freshener and Cotton. (4) The forehead, nose, on either side of the left or right face,
A sample composition such as the cosmetic composition of the present invention is applied to areas that secrete a lot of sebum, mainly around the nostrils. Note that a cosmetic to which no levulinic acid compound was added was applied to the other side of the face as a control. (5) Apply a certain amount of the following foundation to the entire face. (6) 1, 2, and 3. The judge evaluates the state of makeup deterioration after each time. The formulation of the foundation used is as follows. Microwax 10 parts Vaseline 16 Isopropyl myristate 15 Polyoxyethylene cetyl ether (20E.O.
) 6 Antioxidant 0.06 Propylparaben 0.1 Fragrance 0.5 Titanium oxide 22.34 Talc 23.8 Iron oxide 1.5 Yellow ocher 4.1 Carbon black 0.6 Makeup discoloration and color of the present lotion and comparison lotion Tables 1 and 2 show the dullness and prevention effects.
【表】【table】
【表】【table】
【表】【table】
【表】
本発明の化粧水および比較用化粧水の品質特性
および皮脂分泌抑制効果を表3に示す。[Table] Table 3 shows the quality characteristics and sebum secretion suppressing effects of the lotion of the present invention and the comparative lotion.
【表】【table】
【表】
レブリン酸Aおよびその塩類B、C、D、Eの
化粧水も、レブリン酸無添加の化粧水も、外観は
45℃6ケ月後または5℃6ケ月後も製造直後と同
じ無色透明であり、においは、45℃6ケ月後も異
臭がなく良好であつた。
官能特性評価は、塗布3時間後に行ない、前記
の第1表または第2表における評価の、、
を“フアンデーシヨンがくずれなかつた”。また
は、“フアンデーシヨンの色ぐすみがしなかつ
た”。に相当するとした。第3表の官能特性デー
タより、レブリン酸又はその塩類を配合すること
により、フアンデーシヨンを使用した時、フアン
デーシヨンのもちが良く(くずれにくく)なり、
更にはフアンデーシヨンの経時による色ぐすみの
改善されることが明らかになかつた。
皮脂分泌抑制効果は第3表に示したように、い
ずれの試料の場合も塗布後の放置時間が長くなる
に従つて皮脂分泌抑制率は低くなるが、レブリン
酸またはその塩類を配合した化粧水の抑制率はレ
ブリン酸系化合物無添加の化粧水(対照)のそれ
よりも明らかに高く、皮脂分泌の抑制されている
ことが明らかとなつた。
皮脂分泌抑制率と化粧くずれの関係を調べた結
果、化粧くずれは皮脂分泌抑制率が40%以上では
殆んど認められず。抑制率が30%以下でやや目立
つようになり、10%以下では顕著になることが判
明した。すなわち、化粧くずれの発現には皮脂分
泌量のいわば閾値が存在するため、皮脂分泌抑制
率が閾値以上の場合には塗布試料によつて抑制率
が異なつても実際の化粧くずれにはさほど差が認
められない。
実施例 2
レブリン酸の配合量を第4表の如く変化させ、
かつ処方の全量が100部となるよう水の使用量を
変化させる他は、実施例1の本発明と同様にして
化粧水を調製した。その結果を第4表に示した。
第4表の結果から明らかなように、本発明にお
けるレブリン酸の使用量は、処方成分の総量を基
準として0.0001〜0.04重量%である。
0.0001重量%よりも少なくなると皮脂分泌抑制
率(効果)および化粧くずれ防止効果が低下し、
また0.04重量%を超えると眼粘膜刺激を感じ好ま
しくない。[Table] The appearance of lotions containing levulinic acid A and its salts B, C, D, and E, as well as lotions without the addition of levulinic acid.
Even after 6 months at 45°C or 6 months at 5°C, it remained as clear and colorless as it was immediately after production, and the odor remained good with no off-odor even after 6 months at 45°C. Sensory characteristic evaluation was carried out 3 hours after application, and the evaluation in Table 1 or Table 2 above was performed.
"The foundation remained intact." Or, "The color of the foundation did not fade." It is considered to be equivalent to From the sensory property data in Table 3, by blending levulinic acid or its salts, when the foundation is used, it becomes more durable (does not easily fall apart),
Furthermore, it was not clear that the dullness of color due to aging of the foundation was improved. As for the sebum secretion suppressing effect, as shown in Table 3, for all samples, the longer the time after application, the lower the sebum secretion suppressing rate, but the lotion containing levulinic acid or its salts The inhibition rate was clearly higher than that of the lotion without the addition of levulinic acid compounds (control), indicating that sebum secretion was inhibited. As a result of investigating the relationship between sebum secretion suppression rate and makeup deterioration, makeup deterioration was hardly observed when the sebum secretion suppression rate was 40% or higher. It was found that it became somewhat noticeable when the suppression rate was 30% or less, and became noticeable when the suppression rate was 10% or less. In other words, since there is a so-called threshold of sebum secretion for the appearance of makeup deterioration, if the sebum secretion suppression rate is above the threshold, even if the suppression rate differs depending on the applied sample, there will not be much difference in actual makeup deterioration. unacceptable. Example 2 The amount of levulinic acid was varied as shown in Table 4,
A lotion was prepared in the same manner as in Example 1 of the present invention, except that the amount of water used was varied so that the total amount of the formulation was 100 parts. The results are shown in Table 4. As is clear from the results in Table 4, the amount of levulinic acid used in the present invention is 0.0001 to 0.04% by weight based on the total amount of prescription ingredients. When the amount is less than 0.0001% by weight, the sebum secretion suppression rate (effect) and the effect of preventing makeup from fading will decrease.
Moreover, if it exceeds 0.04% by weight, eye mucosal irritation may occur, which is undesirable.
【表】【table】
【表】
実施例 3
レブリン酸系化合物として、レブリン酸を使用
し、グリセリンの代りに第5表に示す有機多価金
属塩の夫々を用いる他は、実施例1の本発明と同
様にして各化粧水を調製した。
第5表より明らかな如く、レブリン酸と、パラ
フエノールスルホン酸亜鉛、アラントインクロル
ヒドロキシアルミニウム、アラントインジヒドロ
キシアルミニウム、塩基性塩化アルミニウムから
なる群より選択された有機多価金属塩とを併用配
合する場合は、有機多価金属塩を併用しない場合
に比較して皮脂分泌抑制効果がよく優れ、かつフ
アンデーシヨンのもち、(フアンデーシヨンがく
ずれにくい)がより良好で、フアンデーシヨンの
経時による色ぐすみが少ない皮膚化粧用組成物が
得られる。[Table] Example 3 In the same manner as in Example 1 of the present invention, except that levulinic acid was used as the levulinic acid compound and each of the organic polyvalent metal salts shown in Table 5 was used instead of glycerin. A lotion was prepared. As is clear from Table 5, when levulinic acid and an organic polyvalent metal salt selected from the group consisting of zinc paraphenolsulfonate, allantoin chlorohydroxy aluminum, allantoin dihydroxy aluminum, and basic aluminum chloride are combined, , the effect of suppressing sebum secretion is better than when organic polyvalent metal salts are not used together, and the foundation has better longevity (the foundation does not easily crumble), and the color of the foundation does not fade over time. A skin cosmetic composition with less blemish is obtained.
【表】【table】
【表】
実施例 4
レブリン酸系化合物としてレブリン酸を使用
し、グリセリンの代りにパラフエノールスルホン
酸亜鉛を用い、かつその配合量を第6表の如く変
化させる他は、実施例1の本発明と同様にして化
粧水を調製した。その結果を第6表に示した。
第6表の結果から明らかなように、パラフエノ
ールスルホン酸亜鉛の使用量は、処方成分の総量
を基準として高々3.0重量%である。3.0重量%よ
りも多くなると製品の透明性が低下しやすく、ま
た眼粘膜刺激を感じる等、好ましくない結果を与
える傾向がある。[Table] Example 4 The present invention of Example 1 except that levulinic acid was used as the levulinic acid-based compound, zinc paraphenolsulfonate was used instead of glycerin, and the blending amount was changed as shown in Table 6. A lotion was prepared in the same manner. The results are shown in Table 6. As is clear from the results in Table 6, the amount of zinc paraphenolsulfonate used is at most 3.0% by weight based on the total amount of prescription ingredients. When the amount exceeds 3.0% by weight, the transparency of the product tends to decrease, and it tends to give unfavorable results such as irritation of the eye mucous membranes.
【表】【table】
【表】
実施例 5
レブリン酸系化合物としてレブリン酸を使用
し、かつグリセリンの代りに第7表に示す薬用植
物の1・3−ブチレングリコール(1・3−
BG)抽出物を用いる他は、実施例1の本発明と
同様にして化粧水を調製した。その結果を第7表
に示した。
第7表の結果より明らかな如く、ゴボウ、オラ
ンダカラシ、常春ツタ、サボンソウからなる群よ
り選択された薬用植物の1・3−ブチレングリコ
ール抽出物をレブリン酸(レブリン酸系化合物)
と併用する場合は、併用しない場合に比較して、
皮脂分泌抑制効果がより優れ、かつフアンデーシ
ヨンのもちがより良好で(フアンデーシヨンがよ
りくずれにくく)、フアンデーシヨンの経時によ
る色ぐすみがより少ない化粧水が得られる。[Table] Example 5 Levulinic acid was used as the levulinic acid compound, and 1,3-butylene glycol (1,3-
BG) A lotion was prepared in the same manner as in Example 1 of the present invention except that the extract was used. The results are shown in Table 7. As is clear from the results in Table 7, 1,3-butylene glycol extracts of medicinal plants selected from the group consisting of burdock, mustard, evergreen ivy, and soapwort are combined with levulinic acid (levulinic acid-based compounds).
When used together with, compared to when not used together,
To obtain a lotion that has a better effect of suppressing sebum secretion, has a better foundation retention (the foundation is less likely to crumble), and has less fading of the foundation color over time.
【表】【table】
【表】
実施例 6
レブリン酸系化合物としてレブリン酸を使用
し、グリセリンの代りにゴボウの1・3−ブチレ
ングリコール抽出液を用いかつその配合量を第8
表の如く変化させ、処方成分の全量が100部とな
るよう水の配合量部を変化させる他は、実施例1
の本発明と同様にして化粧水を調製した。その結
果を第8表に示した。
第8表から明らかな如く、ゴボウの1・3−ブ
チレングリコール抽出物(1・3−BG抽出物)
の使用量は高々2.0重量%である。2.0重量%を越
すと、製品の透明性が低下し、又眼粘膜刺激を感
じる為に好ましくない。[Table] Example 6 Levulinic acid was used as a levulinic acid-based compound, 1,3-butylene glycol extract of burdock was used instead of glycerin, and the blending amount was adjusted to 8.
Example 1 except that the amount of water was changed as shown in the table and the amount of water was changed so that the total amount of prescription ingredients was 100 parts.
A lotion was prepared in the same manner as in the present invention. The results are shown in Table 8. As is clear from Table 8, 1,3-butylene glycol extract of burdock (1,3-BG extract)
The amount used is at most 2.0% by weight. If it exceeds 2.0% by weight, it is not preferable because the transparency of the product decreases and eye mucous membrane irritation occurs.
【表】
実施例 7
レブリン酸系化合物としてレブリン酸ナトリウ
ムを用いかつその配合量を第9表に示す如く変化
させ、処方成分の全量が100部になるように水の
使用量部を変化させる他は、実施例1と同様にし
て各化粧水を調製した。その結果を第9表に示し
た。
レブリン酸ナトリウムも、レブリン酸の場合
(実施例2)と同様に、配合量0.0001〜0.04重量
の範囲内では優れた皮脂分泌抑制効果、および化
粧くずれ防止効果を発現した。[Table] Example 7 Sodium levulinic acid was used as the levulinic acid compound, the amount of the compound was changed as shown in Table 9, and the amount of water used was changed so that the total amount of prescription ingredients was 100 parts. Each lotion was prepared in the same manner as in Example 1. The results are shown in Table 9. Similarly to the case of levulinic acid (Example 2), sodium levulinic acid also exhibited excellent sebum secretion inhibiting effects and makeup fading prevention effects within the range of 0.0001 to 0.04 weight.
【表】
実施例 8
(透明ゲル状の皮膚化粧用組成物)
エタノール20部、香料0.1部、1・3−ブチレ
ングリコール3.0部、カルボキシビニルポリマー
0.2部、水酸化カリウム0.01部、第10表に示すレ
ブリン酸Aまたはその塩を0.001部、色素適量
部、ポリオキシエチレン硬化ヒマシ油(60E.O)
0.2部の組成からなる透明ゲル状の皮膚化粧料を
常法により調製した。その結果を第10表に示し
た。
第10表の結果から明らかなように、レブリン酸
Aまたはその塩B、C、D、Eを透明ゲル状の基
剤に配合しても、ローシヨン基剤(実施例1)に
配合した場合と同様に、優れた皮脂分泌抑制効果
および化粧くずれ防止効果を発揮する。[Table] Example 8 (Transparent gel-like skin cosmetic composition) 20 parts of ethanol, 0.1 part of fragrance, 3.0 parts of 1,3-butylene glycol, carboxyvinyl polymer
0.2 part, potassium hydroxide 0.01 part, 0.001 part of levulinic acid A or its salt shown in Table 10, appropriate amount of pigment, polyoxyethylene hydrogenated castor oil (60E.O)
A transparent gel-like skin cosmetic having a composition of 0.2 parts was prepared by a conventional method. The results are shown in Table 10. As is clear from the results in Table 10, even when levulinic acid A or its salts B, C, D, and E are blended into a transparent gel-like base, there is no effect when blended with a lotion base (Example 1). Similarly, it exhibits an excellent sebum secretion suppressing effect and an effect of preventing makeup from fading.
Claims (1)
化粧料基剤に処方成分の総量を基準として0.0001
〜0.04重量%配合してなる皮脂分泌抑制効果の優
れた皮膚化粧用組成物。 2 レブリン酸および/またはその塩が、処方成
分の総量に対して0.001〜0.01重量%配合されて
いる特許請求の範囲第1項記載の皮膚化粧用組成
物。 3 レブリン酸の塩が、レブリン酸のアンモニウ
ム塩、アルカリ金属塩、アルカリ土類金属塩、ま
たはアルカノールアミン塩である特許請求の範囲
第1項記載の皮膚化粧用組成物。 4 更に、パラフエノールスルホン酸亜鉛、アラ
ントインクロルヒドロキシアルミニウム、アラン
トインジヒドロキシアルミニウム、塩基性塩化ア
ルミニウムからなる群より選択された有機多価金
属塩の少なくとも一つが、処方成分の総量を基準
として高々3.0重量%配合されている特許請求の
範囲第1項記載の皮膚化粧用組成物。 5 更にゴボウ、オランダカラシ、常春ツタ、サ
ボウソウからなる群より選択された薬用植物の少
なくとも一つの1・3−ブチレングリコール抽出
物が、処方成分の総量を基準として乾燥固形分当
り高々2.0重量%配合されている特許請求の範囲
第1項記載の皮膚化粧用組成物。 6 水性の化粧料基剤が、ローシヨン状化粧料又
は透明ゲル状化粧料の基剤である特許請求の範囲
第1項記載の皮膚化粧用組成物。[Claims] 1. Levulinic acid and/or its salts are added to an aqueous cosmetic base in an amount of 0.0001% based on the total amount of prescription ingredients.
A skin cosmetic composition with an excellent sebum secretion suppressing effect, containing ~0.04% by weight. 2. The skin cosmetic composition according to claim 1, wherein levulinic acid and/or its salt is blended in an amount of 0.001 to 0.01% by weight based on the total amount of prescription ingredients. 3. The skin cosmetic composition according to claim 1, wherein the salt of levulinic acid is an ammonium salt, an alkali metal salt, an alkaline earth metal salt, or an alkanolamine salt of levulinic acid. 4. Furthermore, at least one organic polyvalent metal salt selected from the group consisting of zinc paraphenolsulfonate, allantoin chloroaluminum, allantoin dihydroxyaluminum, and basic aluminum chloride in an amount of at most 3.0% by weight based on the total amount of prescription ingredients. A dermocosmetic composition according to claim 1, in which the composition is formulated. 5. Furthermore, at least 1,3-butylene glycol extract of at least one medicinal plant selected from the group consisting of burdock, mustard, evergreen ivy, and saberweed is included in an amount of at most 2.0% by weight per dry solid content based on the total amount of prescription ingredients. A skin cosmetic composition according to claim 1. 6. The skin cosmetic composition according to claim 1, wherein the aqueous cosmetic base is a base for a lotion-like cosmetic or a transparent gel-like cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58039768A JPS59164712A (en) | 1983-03-09 | 1983-03-09 | Skin makeup composition having improved inhibitory action on sebum secretion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58039768A JPS59164712A (en) | 1983-03-09 | 1983-03-09 | Skin makeup composition having improved inhibitory action on sebum secretion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59164712A JPS59164712A (en) | 1984-09-17 |
| JPS6158442B2 true JPS6158442B2 (en) | 1986-12-11 |
Family
ID=12562109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58039768A Granted JPS59164712A (en) | 1983-03-09 | 1983-03-09 | Skin makeup composition having improved inhibitory action on sebum secretion |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59164712A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0439646U (en) * | 1990-07-30 | 1992-04-03 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4677063B2 (en) * | 1997-07-18 | 2011-04-27 | 帝國製薬株式会社 | Dutch mustard extract combination external preparation |
| JP4450456B2 (en) | 1999-09-27 | 2010-04-14 | 株式会社マルハニチロ水産 | Sebum production inhibitor |
| JP2002047125A (en) * | 2000-05-26 | 2002-02-12 | Shiseido Co Ltd | Skin care preparation for inhibiting sebum secretion |
| DE102004033206A1 (en) * | 2004-07-09 | 2006-02-09 | Wella Ag | Use of oxo-carboxylic acid-containing combinations for deodorization |
| KR101252550B1 (en) | 2006-03-06 | 2013-04-08 | (주)아모레퍼시픽 | Cosmetic composition for protecting sebum secretion on the skin |
| JP5117732B2 (en) * | 2007-01-29 | 2013-01-16 | 株式会社 メドレックス | Hypoallergenic dissolution aid for external use |
| AU2011250962B2 (en) | 2010-05-10 | 2015-09-03 | Gfbiochemicals Limited | Personal care formulations containing alkyl ketal esters and methods of manufacture |
| FR2988607B1 (en) | 2012-03-27 | 2016-07-15 | Oreal | USE OF A CULTURE LYSATE OF A BACTERIUM OF THE GENUS VITREOSCILLA SP. FOR PREVENTING AND / OR TREATING HYPERSEBORRHEIC CONDITIONS OF SCALP. |
| WO2013144870A1 (en) | 2012-03-27 | 2013-10-03 | L'oreal | Use of a lysate from the culture of one or more bacteria for preventing and/or treating hyperseborrhea conditions of the scalp |
| JP2016506383A (en) | 2012-11-29 | 2016-03-03 | サジティス・インコーポレイテッド | Carboxyester ketal, process for its production and use |
-
1983
- 1983-03-09 JP JP58039768A patent/JPS59164712A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0439646U (en) * | 1990-07-30 | 1992-04-03 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59164712A (en) | 1984-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3871640T2 (en) | COSMETIC COMPOSITION. | |
| US4126142A (en) | Face mask | |
| JP4767914B2 (en) | Cosmetic composition that has an effect of tightening the skin | |
| MXPA97004778A (en) | Formulations to reduce skin irritations and use of mis | |
| KR102233140B1 (en) | Cosmetic composition for skin improvement containing low molecular weight hyaluronic acid | |
| CA2207783C (en) | Antiperspirant or deodorant composition comprising a moisturizing cream | |
| JPS6158442B2 (en) | ||
| JP2005187474A (en) | Improved cosmetics | |
| CN113768809B (en) | Composition with mild exfoliating effect and preparation method and application thereof | |
| KR101794555B1 (en) | Cosmetic composition for protecting lip comprising natural ceramide and rosa canina fruit oil | |
| CA2361175A1 (en) | A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating | |
| KR100849100B1 (en) | Cosmetic composition for exfoliating skin and preparation method thereof | |
| CN115252458A (en) | Stable moisturizing composition containing blue copper peptide | |
| JP4716354B2 (en) | Skin cleansing agent and skin cleansing method | |
| JP2013136533A (en) | Anti-aging cosmetic | |
| JP2001114635A (en) | Cosmetic composition containing brown sugar extract | |
| EP3226827B1 (en) | Aluminium-free antiperspirant/deodorant compositions and method of preparing the same | |
| JPS62209010A (en) | Cosmetic | |
| JPS62209009A (en) | Cosmetic | |
| CN109745262B (en) | Composition for whitening spot-fading face cream | |
| JP2009221173A (en) | Keratin status ameliorator | |
| JP6486590B2 (en) | Anti-aging agent | |
| KR102850158B1 (en) | Composition for skin care | |
| KR102223208B1 (en) | Cosmetic composition for anti-wrinkles and preventing white cast | |
| JP2008184395A (en) | Antiperspirant / deodorant cosmetic and method for producing the same |